Results 151 to 160 of about 80,047 (217)

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis

Background: Therapeutic efcacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potentially preclude/pre-empt the detection of subsequent recrudescence of ...
Bassat Orellana, Quique, WorldWide Antimalarial Resistance Network Methodology Study Group   +1 more
core  

Antimalarial medicine diversion: stock-outs and other public health problems

, 2010
Roger Bate1,2, Kimberly Hess2, Lorraine Mooney31American Enterprise Institute, Washington, D.C., USA; 2Africa Fighting Malaria, Washington, D.C., USA; 3Africa Fighting Malaria, Cambridge, UKBackground: Antimalarial medicine diversion has been seen across
Roger Bate, Kimberly Hess, Lorraine Mooney   +2 more
core  

Biological Activity of <i>Artemisia mexicana</i>: Antimalarial, Immunomodulatory, and Antioxidant Effects in Experimental Malaria. [PDF]

Int J Mol Sci
López-Padilla MS, Cervantes-Candelas LA, Aguilar-Castro J, Nolasco-Pérez TJ, Buendía-González FO, Avila-Acevedo JG, Estrella-Parra EA, Legorreta-Herrera M.   +7 more
europepmc   +1 more source

Nearly one in five essential medicines fail quality standards in Africa: A systematic review and meta-analysis of MNCH medicines and antimalarials. [PDF]

PLOS Glob Public Health
Rusatira JC, Novoa MD, Uwimana JB, Persaud C, Pal E, Khan A, Michtalik H, Padayachee N, Lumpkin M, Preston C, Ahmed S.   +10 more
europepmc   +1 more source

Nanoparticle based drug delivery systems improve antimalarial efficacy and vaccine performance in African research and clinical settings. [PDF]

Discov Nano
Dangana RS, Ebhohimen IE, Otele IM, Idiakheua OD, Okpeku M.   +4 more
europepmc   +1 more source

Understanding barriers to effective malaria diagnosis and treatment: A mixed-methods study in Uganda, Nigeria, and Ivory Coast. [PDF]

PLOS Glob Public Health
Otsyula N, Polavarapu NK, Syntosi A, Bench W, Kaur G, Meadows A, West RL, Dewhurst M, Mishra PK, Obi IO, Idayat Adigun O, Odongo EN, Nanziri P, Boulton C.   +13 more
europepmc   +1 more source

Comparative efficacy of free and PNAGA-encapsulated antimalarial drugs: temperature-dependent modulation of <i>Plasmodium falciparum</i> growth. [PDF]

Front Pharmacol
Mutangadura D, Mushonga P, Mduluza T.
europepmc   +1 more source

Design, Synthesis, and Evaluation of New 1,4-Naphthoquinone-1,2,3-triazoles as Antimalarial Agents. [PDF]

Chem Biodivers
Rezainia L, Sayahi MH, Vernousfaderani EK, Mirfazli SS, Morshedsolouk MH, Dastyafteh N, Nateghpour M, Farivar L, Saeedi M, Hanifian H, Mohebali M, Shafiee SM, Hassanpour G, Mahdavi M.   +13 more
europepmc   +1 more source

How selection was made for a new antimalarial drug candidate : from AM1 to MG3, two novel series of 4-aminoquinoline derivatives

, 2011
Introduction Within AntiMal, our studies were focused on novel 4-aminoquinolines bearing a terminal bulky bicyclic basic moiety able to overcome parasite resistance.
C. Rusconi, N. Vaiana, Y. Corbett, L. Cortelezzi, S. Romeo, D. Taramelli, M. Casagrande, D. Scaccabarozzi, A. Sparatore, F. Omodeo Salè, V. Tazzari, N. Basilico   +11 more
core  

Improving the field accuracy of a malaria diagnostic algorithm combining sequential interpretation of rapid diagnostic test detecting PfHRP2 and pLDH in febrile children in a seasonal hyperendemic malaria transmission area in Burkina Faso. [PDF]

PLoS One
Some DY, Kiemde F, Kabore B, Valia D, Rouamba T, Sawadogo S, Some AM, Sorgho H, Nana M, Nombre Y, Kone NA, Compaore A, Bocoum FY, Bonko MDA, Some G, Tougri G, Youl SY, Noellie K, Hien YE, Savadogo A, Koueta F, Schallig HDFH, Tinto H.   +22 more
europepmc   +1 more source